Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079313
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2004-03-08
Brief Title:
Imatinib GleevecRegistered Trademark to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-01-14
Start Date Type:
None
Primary Completion Date:
2006-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10-25
Completion Date Type:
ACTUAL
First Submit Date:
2004-03-08
First Submit QC Date:
March 9 2004
Study First Post Date:
2004-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-30
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL